Polo-like kinase and survivin are esophageal tumor-specific promoters

Biochemical and Biophysical Research Communications

Volumn 342, Issue 2, 2006, Pages 465-471

  Sato, Fumiaki ^a,b   Abraham, John M ^a   Yin, Jing ^a   Kan, Takatsugu ^a   Ito, Tetsuo ^a   Mori, Yuriko ^a,b   Hamilton, James P ^a   Jin, Zhe ^a   Cheng, Yulan ^a   Paun, Bogdan ^a   Berki, Agnes T ^a   Wang, Suna ^a   Shimada, Yutaka ^c   Meltzer, Stephen J ^a,b,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c KYOTO UNIVERSITY   (Japan)

^d BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Esophageal cancer; Gene therapy; Microarray; Tumor specific promoter

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CYCLOOXYGENASE 2; GENE PTTG1; KARYOPHERIN ALPHA; KARYOPHERIN ALPHA 2; LUCIFERASE; MESSENGER RNA; POLO LIKE KINASE; SURVIVIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS TUMOR; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALPHA KARYOPHERINS; CELL CYCLE PROTEINS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 33344478035     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.01.177     Document Type: Article

References (34)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J. Clin. 55 2005 74 108
2. WHO, World Cancer Report, ed., IARC Press, Lyon, 2003.
3. D.S. Schrump, G.A. Chen, U. Consuli, X. Jin, and J.A. Roth Inhibition of esophageal cancer proliferation by adenovirally mediated delivery of p16INK4 Cancer Gene Ther. 3 1996 357 364
4. T. Itoshima, T. Fujiwara, T. Waku, J. Shao, M. Kataoka, W.G. Yarbrough, T.J. Liu, J.A. Roth, N. Tanaka, and M. Kodama Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation Clin. Cancer Res. 6 2000 2851 2859
5. Y. Kadowaki, T. Fujiwara, T. Fukazawa, J. Shao, T. Yasuda, T. Itoshima, S. Kagawa, L.G. Hudson, J.A. Roth, and N. Tanaka Induction of differentiation-dependent apoptosis in human esophageal squamous cell carcinoma by adenovirus-mediated p21sdi1 gene transfer Clin. Cancer Res. 5 1999 4233 4241
6. Y. Tango, T. Fujiwara, T. Itoshima, Y. Takata, K. Katsuda, F. Uno, S. Ohtani, T. Tani, J.A. Roth, and N. Tanaka Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells Hum. Gene Ther. 13 2002 1373 1382
7. P. Zhou, W. Jiang, Y.J. Zhang, S.M. Kahn, I. Schieren, R.M. Santella, and I.B. Weinstein Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells Oncogene 11 1995 571 580
8. X. Ye, and M. Wu Retrovirus mediated transfer of antisense human c-myc gene into human esophageal cancer cells suppressed cell proliferation and malignancy Sci. China B 35 1992 76 83
9. Z.P. Gu, Y.J. Wang, J.G. Li, and Y.A. Zhou VEGF165 antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma World J. Gastroenterol. 8 2002 44 48
10. H. Shimada, T. Shimizu, T. Ochiai, T.L. Liu, H. Sashiyama, A. Nakamura, H. Matsubara, Y. Gunji, S. Kobayashi, M. Tagawa, S. Sakiyama, and T. Hiwasa Preclinical study of adenoviral p53 gene therapy for esophageal cancer Surg. Today 31 2001 597 604
11. T. Shirakawa, K. Hamada, Z. Zhang, H. Okada, M. Tagawa, S. Kamidono, M. Kawabata, and A. Gotoh A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells Clin. Cancer Res. 10 2004 4342 4348
12. Y.S. Haviv, W.J. van Houdt, B. Lu, D.T. Curiel, and Z.B. Zhu Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter Mol. Cancer Ther. 3 2004 687 691
13. J. Kamizono, S. Nagano, Y. Murofushi, S. Komiya, H. Fujiwara, T. Matsuishi, and K. Kosai Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication Cancer Res. 65 2005 5284 5291
14. J. Qiao, M. Doubrovin, B.V. Sauter, Y. Huang, Z.S. Guo, J. Balatoni, T. Akhurst, R.G. Blasberg, J.G. Tjuvajev, S.H. Chen, and S.L. Woo Tumor-specific transcriptional targeting of suicide gene therapy Gene Ther. 9 2002 168 175
15. Y. Shimada, M. Imamura, T. Wagata, N. Yamaguchi, and T. Tobe Characterization of 21 newly established esophageal cancer cell lines Cancer 69 1992 277 284
16. R.F. Souza, K. Shewmake, D.G. Beer, B. Cryer, and S.J. Spechler Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells Cancer Res. 60 2000 5767 5772
17. Y.H. Yang, S. Dudoit, P. Luu, D.M. Lin, V. Peng, J. Ngai, and T.P. Speed Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation Nucleic Acids Res. 30 2002 e15
18. F.A. Barr, H.H. Sillje, and E.A. Nigg Polo-like kinases and the orchestration of cell division Nat. Rev. Mol. Cell Biol. 5 2004 429 440
19. U. Holtrich, G. Wolf, A. Brauninger, T. Karn, B. Bohme, H. Rubsamen-Waigmann, and K. Strebhardt Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors Proc. Natl. Acad. Sci. USA 91 1994 1736 1740
20. G. Wolf, R. Elez, A. Doermer, U. Holtrich, H. Ackermann, H.J. Stutte, H.M. Altmannsberger, H. Rubsamen-Waigmann, and K. Strebhardt Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer Oncogene 14 1997 543 549
21. Y. Tokumitsu, M. Mori, S. Tanaka, K. Akazawa, S. Nakano, and Y. Niho Prognostic significance of polo-like kinase expression in esophageal carcinoma Int. J. Oncol. 15 1999 687 692
22. F. Li, G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, and D.C. Altieri Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
23. J. Kato, Y. Kuwabara, M. Mitani, N. Shinoda, A. Sato, T. Toyama, A. Mitsui, T. Nishiwaki, S. Moriyama, J. Kudo, and Y. Fujii Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy Int. J. Cancer 95 2001 92 95
24. J.A. Bernal, R. Luna, A. Espina, I. Lazaro, F. Ramos-Morales, F. Romero, C. Arias, A. Silva, M. Tortolero, and J.A. Pintor-Toro Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis Nat. Genet. 32 2002 306 311
25. K. Weis, U. Ryder, and A.I. Lamond The conserved amino-terminal domain of hSRP1 alpha is essential for nuclear protein import EMBO J. 15 1996 1818 1825
26. T. Uchiumi, D.L. Longo, and D.K. Ferris Cell cycle regulation of the human polo-like kinase (PLK) promoter J. Biol. Chem. 272 1997 9166 9174
27. W.H. Hoffman, S. Biade, J.T. Zilfou, J. Chen, and M. Murphy Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 J. Biol. Chem. 277 2002 3247 3257
28. F. Li, and D.C. Altieri Transcriptional analysis of human survivin gene expression Biochem. J. 344 Pt. 2 1999 305 311
29. C. Zhou, S. Liu, X. Zhou, L. Xue, L. Quan, N. Lu, G. Zhang, J. Bai, Y. Wang, Z. Liu, Q. Zhan, H. Zhu, and N. Xu Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin/TCF pathway in human esophageal squamous cell carcinoma Int. J. Cancer 113 2005 891 898
30. A.L. Clem, T. Hamid, and S.S. Kakar Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells Gene 322 2003 113 121
31. T. Zhang, T. Otevrel, Z. Gao, S.M. Ehrlich, J.Z. Fields, and B.M. Boman Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer Cancer Res. 61 2001 8664 8667
32. X. Liu, and R.L. Erikson Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells Proc. Natl. Acad. Sci. USA 100 2003 5789 5794
33. M. Nogawa, T. Yuasa, S. Kimura, M. Tanaka, J. Kuroda, K. Sato, A. Yokota, H. Segawa, Y. Toda, S. Kageyama, T. Yoshiki, Y. Okada, and T. Maekawa Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer J. Clin. Invest. 115 2005 978 985
34. H. Uchida, T. Tanaka, K. Sasaki, K. Kato, H. Dehari, Y. Ito, M. Kobune, M. Miyagishi, K. Taira, H. Tahara, and H. Hamada Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo Mol. Ther. 10 2004 162 171